Analysts Boost Targets as Colgate-Palmolive Posts Strong Quarterly Performance

Colgate-Palmolive has demonstrated notable operational resilience in a turbulent consumer goods market, surpassing expectations with its latest quarterly earnings. The company’s core business continues to thrive, even as a significant non-cash impairment charge in its skincare unit created a one-time accounting effect. Following substantial price target revisions from major banks, investors are assessing the durability of the firm’s current momentum.

The response from Wall Street analysts was swift following the earnings release. Multiple institutions raised their valuation models on Monday. Both Bank of America and Morgan Stanley increased their price targets to $100. Morgan Stanley maintained its “Overweight” rating on the shares, citing improved organic growth and solid profitability within Read more...